Cecilia Carnrot

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial”.

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00312-8

N/A

1.3DataRank · unranked

45 citations

Wilmina F. Kalinga, Jo Salkeld, Ivanny M. Mtaka, Saumu Ahmed, Florence A. Milando +38 more

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101654

N/A

0.695DataRank · unranked

23 citations

David Pulido, Jordan R. Barrett, H. Dele Davies, Doris Quinkert, Amelia M. Lias +33 more

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Nature Communications(2024)10.1038/s41467-024-48721-3

N/A

0DataRank · unranked

33 citations

Lloyd D. W. King, David Pulido, Doris Quinkert, Amelia M. Lias, Sarah E. Silk +29 more

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.08.579322

N/A

0DataRank · unranked

1 citations

Lloyd D. W. King, David Pulido, Doris Quinkert, Amelia M. Lias, Sarah E. Silk +29 more